MYMasami Yoneyama

Masami Yoneyama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Masami Yoneyama has a total of 186 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Spectral presaturation with inversion recovery provides superior neuromelanin imaging for Parkinson’s disease evaluation compared to magnetization transfer

    by Tomoki Imokawa, Hiroyuki Maki, Midori Kusama, Risa Kagaya, Yoko Shigemoto, Yukio Kimura, Hiroshi Matsuda, Masami Yoneyama, Takashi Namiki, Yohei Mukai, et al.

    Purpose Neuromelanin-sensitive imaging visualizes degeneration of the substantia nigra pars compacta (SNc) and locus coeruleus (LC), characteristic features of Parkinson’s disease (PD). Spectral presaturation with inversion recovery (SPIR), using fat-selective radiofrequency pulses, has been reported to provide superior delineation of the SNc and LC in healthy individuals and offers shorter acquisition times than conventional magnetization transfer (MT) imaging. This study evaluated the clinical utility of SPIR imaging for assessing PD compared with MT imaging. Methods Neuromelanin-sensitive images were acquired from 24 patients with PD and 24 healthy controls using MT and SPIR sequences, each with an acquisition time of approximately five minutes. Signal ratios (SRs) of the SNc and LC were automatically quantified using established brain atlases. For each sequence and brain region, diagnostic performance in distinguishing PD from controls was assessed using receiver operating characteristic curve analysis. In patients with PD, associations between SRs and nigrostriatal degeneration, as measured by dopamine transporter SPECT imaging, were investigated. Results SPIR images yielded higher SRs in the SNc than MT images. Diagnostic accuracy for PD with SPIR imaging (87.50%) was significantly greater than that with MT imaging (77.08%). SRs of the SNc and LC on SPIR images were correlated with nigrostriatal degeneration on dopamine transporter SPECT, unlike MT images. Conclusion SPIR imaging demonstrated superior visualization of the SNc and LC, and outperformed MT imaging in the evaluation of PD. With shorter acquisition time and stronger correlation with nigrostriatal degeneration, SPIR represents a promising and practical tool for diagnosing and monitoring PD.


  • Coronary artery black-blood imaging via T2-prepared phase-sensitive inversion-recovery steady-state free precession in Kawasaki disease

    by Koji Matsumoto, Hajime Yokota, Hiroki Mukai, Ryota Ebata, Kentaro Okunushi, Hiromichi Hamada, Hiroyuki Takaoka, Masami Yoneyama, Takashi Namiki, Takashi Iimori, et al.

  • Usefulness of 3T split acquisition fast spin-echo diffusion-weighted imaging for differentiating pituitary abscess from other sellar cystic lesions: a preliminary study

    by Soichiro Ishiuchi, Hiroyuki Uetani, Naoki Shinojima, Takeshi Nakaura, Mika Kitajima, Kosuke Morita, Kouji Ogasawara, Masami Yoneyama, Akitake Mukasa, Toshinori Hirai

    Purpose Pituitary abscess is a rare condition that can be challenging to distinguish from other sellar cystic lesions (OSCLs) due to no specific symptoms and overlapping imaging features. Accurate differentiation is crucial for appropriate treatment planning. This study aimed to evaluate the usefulness of 3T split acquisition fast spin-echo diffusion-weighted imaging (SPLICE-DWI) in differentiating pituitary abscesses from OSCLs. Methods We retrospectively analyzed magnetic resonance imaging (MRI) data from 32 patients with sellar cystic lesions, including 5 with pathologically confirmed pituitary abscesses and 27 with OSCLs. Conventional MRI sequences and SPLICE-DWI were performed, and apparent diffusion coefficient (ADC) values were calculated. Qualitative assessments of signal intensity on SPLICE-DWI and conventional MRI were conducted by two neuroradiologists. The diagnostic performance of these imaging parameters was evaluated using receiver operating characteristic (ROC) analysis. Results SPLICE-DWI successfully differentiated pituitary abscesses from OSCLs, showing significantly lower ADC values in the abscess group compared to OSCLs (0.62 ± 0.07 × 10− 3 mm²/s vs. 1.83 ± 0.70 × 10− 3 mm²/s, P = 0.002). ROC analysis revealed high diagnostic accuracy for DWI signal intensity (AUC = 0.89) and ADC values (AUC = 0.95). No significant differences were found in contrast-enhanced T1-weighted imaging (T1WI) features such as ring enhancement, pituitary stalk enlargement, or sphenoid sinus mucosal thickening between the two groups. Conclusion SPLICE-DWI is a valuable tool for the differentiation of pituitary abscesses from OSCLs, offering high diagnostic accuracy.


  • Open Access

    Two for One—Combined Morphologic and Quantitative Knee Joint MRI Using a Versatile Turbo Spin-Echo Platform

    by Teresa Lemainque, Nicola Pridöhl, Marc Huppertz, Manuel Post, Can Yüksel, Robert Siepmann, Karl Ludger Radke, Shuo Zhang, Masami Yoneyama, Andreas Prescher, et al.

    Quantitative MRI techniques such as T2 and T1ρ mapping are beneficial in evaluating knee joint pathologies; however, long acquisition times limit their clinical adoption. MIXTURE (Multi-Interleaved X-prepared Turbo Spin-Echo with IntUitive RElaxometry) provides a versatile turbo spin-echo (TSE) platform for simultaneous morphologic and quantitative joint imaging. Two MIXTURE sequences were designed along clinical requirements: “MIX1”, combining proton density (PD)-weighted fat-saturated (FS) images and T2 mapping (acquisition time: 4:59 min), and “MIX2”, combining T1-weighted images and T1ρ mapping (6:38 min). MIXTURE sequences and their reference 2D and 3D TSE counterparts were acquired from ten human cadaveric knee joints at 3.0 T. Contrast, contrast-to-noise ratios, and coefficients of variation were comparatively evaluated using parametric tests. Clinical radiologists (n = 3) assessed diagnostic quality as a function of sequence and anatomic structure using five-point Likert scales and ordinal regression, with a significance level of α = 0.01. MIX1 and MIX2 had at least equal diagnostic quality compared to reference sequences of the same image weighting. Contrast, contrast-to-noise ratios, and coefficients of variation were largely similar for the PD-weighted FS and T1-weighted images. In clinically feasible scan times, MIXTURE sequences yield morphologic, TSE-based images of diagnostic quality and quantitative parameter maps with additional insights on soft tissue composition and ultrastructure.


  • MR Fingerprinting for Contrast Agent–free and Quantitative Characterization of Focal Liver Lesions

    by Shohei Fujita, Katsuhiro Sano, Gastao Cruz, Carlos Velasco, Hideo Kawasaki, Yuki Fukumura, Masami Yoneyama, Akiyoshi Suzuki, Kotaro Yamamoto, Yuichi Morita, et al.

    Purpose To evaluate the feasibility of liver MR fingerprinting (MRF) for quantitative characterization and diagnosis of focal liver lesions. Materials and Methods This single-site, prospective study included 89 participants (mean age, 62 years ± 15 [SD]; 45 women, 44 men) with various focal liver lesions who underwent MRI between October 2021 and August 2022. The participants underwent routine clinical MRI, non-contrast-enhanced liver MRF, and reference quantitative MRI with a 1.5-T MRI scanner. The bias and repeatability of the MRF measurements were assessed using linear regression, Bland-Altman plots, and coefficients of variation. The diagnostic capability of MRF-derived T1, T2, T2*, proton density fat fraction (PDFF), and a combination of these metrics to distinguish benign from malignant lesions was analyzed according to the area under the receiver operating characteristic curve (AUC). Results Liver MRF measurements showed moderate to high agreement with reference measurements (intraclass correlation = 0.94, 0.77, 0.45, and 0.61 for T1, T2, T2*, and PDFF, respectively), with underestimation of T2 values (mean bias in lesion = -0.5%, -29%, 5.8%, and -8.2% for T1, T2, T2*, and PDFF, respectively). The median coefficients of variation for repeatability of T1, T2, and T2* values were 2.5% (IQR, 3.6%), 3.1% (IQR, 5.6%), and 6.6% (IQR, 13.9%), respectively. After considering multicollinearity, a combination of MRF measurements showed a high diagnostic performance in differentiating benign from malignant lesions (AUC = 0.92 [95% CI: 0.86, 0.98]). Conclusion Liver MRF enabled the quantitative characterization of various focal liver lesions in a single breath-hold acquisition. Keywords: MR Imaging, Abdomen/GI, Liver, Imaging Sequences, Technical Aspects, Tissue Characterization, Technology Assessment, Diagnosis, Liver Lesions, MR Fingerprinting, Quantitative Characterization Supplemental material is available for this article. © RSNA, 2023.


  • Accelerating TOF-MRA: The impact of the combined use of compressed sensitivity encoding and spiral imaging

    by Kosuke Morita, Hiroyuki Uetani, Takeshi Nakaura, Masami Yoneyama, Yasunori Nagayama, Masafumi Kidoh, Naoki Shinojima, Tadashi Hamasaki, Akitake Mukasa, Toshinori Hirai

  • MR Fingerprinting for Liver Tissue Characterization: A Histopathologic Correlation Study

    by Shohei Fujita, Katsuhiro Sano, Gastao Cruz, Yuki Fukumura, Hideo Kawasaki, Issei Fukunaga, Yuichi Morita, Masami Yoneyama, Koji Kamagata, Osamu Abe, et al.

    MR fingerprinting provided repeatable T1, T2, T2*, and fat-fraction maps with high correlation to multiple breath-hold methods and pathologic grades in diffuse liver disease. Background Liver MR fingerprinting (MRF) enables simultaneous quantification of T1, T2, T2*, and proton density fat fraction (PDFF) maps in single breath-hold acquisitions. Histopathologic correlat...


  • Open Access

    Author Correction: Liver diffusion‑weighted MR imaging with L1‑regularized iterative sensitivity encoding reconstruction based on single‑shot echo‑planar imaging: initial clinical experience

    by Maike Bode, Shuo Zhang, Mark N. Terwolbeck, Caroline Molavi Tabrizi, Paul Sprenger, Masami Yoneyama, Nils A. Kraemer, Christiane K. Kuhl, Alexandra Barabasch

  • Open Access

    Amide proton transfer imaging for the determination of human papillomavirus status in patients with oropharyngeal squamous cell carcinoma

    by Noriyuki Fujima, Yukie Shimizu, Masami Mt Yoneyama, Junichi Nakagawa, Hiroyuki Kameda, Taisuke Harada, Seijiro Hamada, Takayoshi Suzuki, Nayuta Tsushima, Satoshi Kano, et al.

    The aim of this study was to investigate the utility of amide proton transfer (APT) imaging for the determination of human papillomavirus (HPV) status in patients with oropharyngeal squamous cell carcinoma (SCC). Thirty-one patients with oropharyngeal SCC were retrospectively evaluated. All patients underwent amide proton transfer imaging using a 3T magnetic resonance (MR) unit. Patients were divided into HPV-positive and -negative groups depending on the pathological findings in their primary tumor. In APT imaging, the primary tumor was delineated with a polygonal region of interest (ROI). Signal information in the ROI was used to calculate the mean, standard deviation (SD) and coefficient of variant (CV) of the APT signals (APT mean, APT SD, and APT CV, respectively). The value of APT CV in the HPV-positive group (0.43 ± 0.04) was significantly lower than that in the HPV-negative group (0.48 ± 0.04) (P = .01). There was no significant difference in APT mean (P = .82) or APT SD (P = .13) between the HPV-positive and -negative groups. Receiver operating characteristic (ROC) curve analysis of APT CV had a sensitivity of 0.75, specificity of 0.8, positive predictive value of 0.75, negative predictive value of 0.8, accuracy of 0.77 and area under the curve (AUC) of 0.8. The APT signal in the HPV-negative group was considered heterogeneous compared to the HPV-positive group. This information might be useful for the determination of HPV status in patients with oropharyngeal SCC.


  • Open Access

    Pitfall for systemic artery aneurysms evaluation using electrocardiogram-gated subtracted three-dimensional fast spin echo sequence of magnetic resonance imaging in patients with Kawasaki disease

    by Haruki Nonaka, Takanori Masuda, Masami Yoneyama, Masahiro Tahara, Mio Okano, Yuko Morikawa, Kazuya Sanada, Tomoyasu Sato